When it comes to pre-revenue biotechs, it's often a struggle to build an investment thesis beyond "if the medicine works, the ...
Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...
Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...
The Motley Fool on MSN1d
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green FlagThe company's latest presentation supports the idea that its lead program will make billions.
Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy ...
Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 ...
The Motley Fool on MSN3d
Is Viking Therepautics a Buy Now?Wall Street's been pounding the table on Viking Therapeutics because VK2735 could become the next and best dual GLP-1/GIP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback